National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium
Radiology · 2023
DOI: 10.1148/radiol.222499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiology, 2023. Verfasst von Christoph I Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology, University of Washington School of Medicine, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Can…. Hauptthemen laut MEDLINE: Mammography, Breast Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, AHRQ HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
It is important to establish screening mammography performance benchmarks for quality improvement efforts.
Purpose
To establish performance benchmarks for digital breast tomosynthesis (DBT) screening and evaluate performance trends over time in U.S. community practice. Materials and Methods In this retrospective study, DBT screening examinations were collected from five Breast Cancer Surveillance Consortium (BCSC) registries between 2011 and 2018. Performance measures included abnormal interpretation rate (AIR), cancer detection rate (CDR), sensitivity, specificity, and false-negative rate (FNR) and were calculated based on the American College of Radiology Breast Imaging Reporting and Data System, fifth edition, and compared with concurrent BCSC DM screening examinations, previously published BCSC and National Mammography Database benchmarks, and expert opinion acceptable performance ranges. Benchmarks were derived from the distribution of performance measures across radiologists (n = 84 or n = 73 depending on metric) and were presented as percentiles.
Results
A total of 896 101 women undergoing 2 301 766 screening examinations (458 175 DBT examinations [median age, 58 years; age range, 18-111 years] and 1 843 591 DM examinations [median age, 58 years; age range, 18-109 years]) were included in this study. DBT screening performance measures were as follows: AIR, 8.3% (95% CI: 7.5, 9.3); CDR per 1000 screens, 5.8 (95% CI: 5.4, 6.1); sensitivity, 87.4% (95% CI: 85.2, 89.4); specificity, 92.2% (95% CI: 91.3, 93.0); and FNR per 1000 screens, 0.8 (95% CI: 0.7, 1.0). When compared with BCSC DM screening examinations from the same time period and previously published BCSC and National Mammography Database performance benchmarks, all performance measures were higher for DBT except sensitivity and FNR, which were similar to concurrent and prior DM performance measures. The following proportions of radiologists achieved acceptable performance ranges with DBT: 97.6% for CDR, 91.8% for sensitivity, 75.0% for AIR, and 74.0% for specificity.
Conclusion
In U.S. community practice, large proportions of radiologists met acceptable performance ranges for screening performance metrics with DBT. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Lee and Moy in this issue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Department of Radiology, University of Washington School of Medicine, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, 825 Eastlake Ave E, LG-200, Seattle, WA 98109 (C.I.L., J.M…
ORCID-Profile: Christoph I Lee, Linn Abraham, Diana L Miglioretti, Karla Kerlikowske, Janie M Lee, Brian L Sprague, Anna N A Tosteson, Garth H Rauscher, Erin J A Bowles, Roberta M diFlorio-Alexander, Louise M Henderson
Förderung
- NCI NIH HHS
- AHRQ HHS
- National Cancer Institute
- Patient-Centered Outcomes Research Institute
- Agency for Healthcare Research and Quality
- Lake Champlain Cancer Research Organization
Zitieren
APA
Lee, C. I., Abraham, L., Miglioretti, D. L., Onega, T., Kerlikowske, K., Lee, J. M., Sprague, B. L., Tosteson, A. N. A., Rauscher, G. H., Bowles, E. J. A., diFlorio-Alexander, R. M., Henderson, L. M., & Breast Cancer Surveillance Consortium (2023). National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium. Radiology. https://doi.org/10.1148/radiol.222499
Vancouver
Lee CI, Abraham L, Miglioretti DL, Onega T, Kerlikowske K, Lee JM, et al. National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium. Radiology. 2023. doi:10.1148/radiol.222499
BibTeX
@article{Lee2023,
author = {Lee, Christoph I and Abraham, Linn and Miglioretti, Diana L and Onega, Tracy and Kerlikowske, Karla and Lee, Janie M and Sprague, Brian L and Tosteson, Anna N A and Rauscher, Garth H and Bowles, Erin J A and diFlorio-Alexander, Roberta M and Henderson, Louise M and Breast Cancer Surveillance Consortium, Breast Cancer Surveillance Consortium},
title = {National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium},
journal = {Radiology},
year = {2023},
doi = {10.1148/radiol.222499}
}
EUVIMED